Ionic Capital Management’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q2
Sell
-18,340
Closed -$953K 255
2018
Q1
$953K Sell
18,340
-319,640
-95% -$17.3M 0.06% 171
2017
Q4
$18.1M Buy
337,980
+110,040
+48% +$6.1M 0.75% 21
2017
Q3
$13.9M Buy
227,940
+18,340
+9% +$1.11M 0.56% 28
2017
Q2
$12.8M Hold
209,600
0.69% 31
2017
Q1
$12.7M Buy
209,600
+188,640
+900% +$11.4M 0.78% 29
2016
Q4
$1.18M Sell
20,960
-5,240
-20% -$307K 0.06% 228
2016
Q3
$1.56M Sell
26,200
-1,048,000
-98% -$61.3M 0.07% 206
2016
Q2
$59M Buy
+1,074,200
New +$57.2M 2.62% 6

Other funds holding MRK

Ionic Capital Management's MRK Position: Q1 2022 in Review

Ionic Capital Management sold out of Merck (MRK) in Q1 2022, closing a stake of 3,530 shares — an estimated $271K sold.

Ionic Capital Management first reported a position in MRK in Q1 2017 and held it in 6 quarters. The position peaked at $9.91M in Q4 2017. 2,952 funds tracked by Wall St. Rank hold MRK as of Q1 2022.

  • Ionic Capital Management reported no remaining Merck position as of Q1 2022 after selling out during the quarter.
  • Ionic Capital Management sold 3,530 Merck shares in Q1 2022, an estimated $271K.
  • Ionic Capital Management first reported a position in Merck in Q1 2017 and held it in 6 quarters.
  • Ionic Capital Management's Merck position peaked at $9.91M in Q4 2017.
  • 2,952 funds tracked by Wall St. Rank held Merck as of Q1 2022.

Based on Ionic Capital Management's 13F filing for Q1 2022, filed 16 May 2022.